Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group [Pediatric Oncology]

Conclusion Reduction of therapy to two drugs did not compromise survival outcomes for patients in the IR-GR group, and escalation of therapy with PEI did not significantly improve OS and EFS in patients at HR.

http://jco.ascopubs.org/cgi/content/short/34/6/603?rss=1

Source: Journal of Clinical Oncology - February 9, 2016 Category: Cancer & Oncology Authors: Lopes, Macedo, Aguiar, Barreto, Martins, Sonaglio, Milone, Lima, Almeida, Lopes, Watanabe, D'Andrea, Pianovski, Melaragno, Vianna, Moreira, Bruniera, Zanardo de Oliveira Tags: Germ Cell Tumors Pediatric Oncology Source Type: research